HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 11 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J8522 Capecitabine, oral, 50 mg Valid
J8530 Cyclophosphamide; oral, 25 mg Valid
J8540 Dexamethasone, oral, 0.25 mg Valid
J8541 Dexamethasone (hemady), oral, 0.25 mg Valid
J8560 Etoposide; oral, 50 mg Valid
J8562 Fludarabine phosphate, oral, 10 mg through FY2026 Terminated
J8565 Gefitinib, oral, 250 mg Valid
J8597 Antiemetic drug, oral, not otherwise specified Valid
J8600 Melphalan; oral, 2 mg Valid
J8610 Methotrexate; oral, 2.5 mg Valid
J8611 Methotrexate (jylamvo), oral, 2.5 mg Valid
J8612 Methotrexate (xatmep), oral, 2.5 mg Valid
J8650 Nabilone, oral, 1 mg through FY2026 Terminated
J8655 Netupitant 300 mg and palonosetron 0.5 mg, oral Valid
J8670 Rolapitant, oral, 1 mg Valid
J8700 Temozolomide, oral, 5 mg Valid
J8705 Topotecan, oral, 0.25 mg Valid
J8999 Prescription drug, oral, chemotherapeutic, nos Valid
J9000 Injection, doxorubicin hydrochloride, 10 mg Valid
J9003 Leuprolide injectable (camcevi etm), 1 mg Valid
J9010 Injection, alemtuzumab, 10 mg through FY2026 Terminated
J9011 Injection, datopotamab deruxtecan-dlnk, 1 mg Valid
J9015 Injection, aldesleukin, per single use vial Valid
J9017 Injection, arsenic trioxide, 1 mg Valid
J9019 Injection, asparaginase (erwinaze), 1,000 iu through FY2026 Terminated
J9020 Injection, asparaginase, not otherwise specified, 10,000 units through FY2026 Terminated
J9021 Injection, asparaginase, recombinant, (rylaze), 0.1 mg Valid
J9022 Injection, atezolizumab, 10 mg Valid
J9023 Injection, avelumab, 10 mg Valid
J9024 Injection, atezolizumab, 5 mg and hyaluronidase-tqjs Valid
J9025 Injection, azacitidine, 1 mg Valid
J9026 Injection, tarlatamab-dlle, 1 mg Valid
J9027 Injection, clofarabine, 1 mg Valid
J9028 Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram Valid
J9029 Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose Valid
J9030 Bcg live intravesical instillation, 1 mg Valid
J9031 Bcg (intravesical) per instillation through FY2026 Terminated
J9032 Injection, belinostat, 10 mg Valid
J9033 Injection, bendamustine hydrochloride, not otherwise specified, 1 mg Valid
J9034 Injection, bendamustine hcl (bendeka), 1 mg Valid
J9035 Injection, bevacizumab, 10 mg Valid
J9036 Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg Valid
J9037 Injection, belantamab mafodotin-blmf, 0.5 mg through FY2026 Terminated
J9038 Injection, axatilimab-csfr, 0.1 mg Valid
J9039 Injection, blinatumomab, 1 microgram Valid
J9040 Injection, bleomycin sulfate, 15 units Valid
J9041 Injection, bortezomib, 0.1 mg Valid
J9042 Injection, brentuximab vedotin, 1 mg Valid
J9043 Injection, cabazitaxel, 1 mg Valid
J9044 Injection, bortezomib, not otherwise specified, 0.1 mg through FY2026 Terminated
J9045 Injection, carboplatin, 50 mg Valid
J9046 Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg Valid
J9047 Injection, carfilzomib, 1 mg Valid
J9048 Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg Valid
J9049 Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg Valid
J9050 Injection, carmustine, 100 mg Valid
J9051 Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg Valid
J9052 Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg Valid
J9053 Injection, belantamab mafodotin-blmf, 0.1 mg Valid
J9054 Injection, bortezomib (boruzu), 0.1 mg Valid
J9055 Injection, cetuximab, 10 mg Valid
J9056 Injection, bendamustine hydrochloride (vivimusta), 1 mg Valid
J9057 Injection, copanlisib, 1 mg Valid
J9058 Injection, bendamustine hydrochloride (apotex), 1 mg through FY2026 Terminated
J9059 Injection, bendamustine hydrochloride (baxter), 1 mg through FY2026 Terminated
J9060 Injection, cisplatin, powder or solution, 10 mg Valid
J9061 Injection, amivantamab-vmjw, 2 mg Valid
J9062 Injection, amivantamab 5 mg and hyaluronidase-lpuj Valid
J9063 Injection, mirvetuximab soravtansine-gynx, 1 mg Valid
J9064 Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg Valid
J9065 Injection, cladribine, per 1 mg Valid
J9066 Injection, bendamustine hydrochloride (avyxa), 1 mg Valid
J9070 Cyclophosphamide, 100 mg through FY2026 Terminated
J9071 Injection, cyclophosphamide (auromedics), 5 mg Valid
J9072 Injection, cyclophosphamide (frindovyx), 5 mg Valid
J9073 Injection, cyclophosphamide (dr. reddy's), 5 mg Valid
J9074 Injection, cyclophosphamide (sandoz), 5 mg Valid
J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg Valid
J9076 Injection, cyclophosphamide (baxter), 5 mg Valid
J9098 Injection, cytarabine liposome, 10 mg through FY2026 Terminated
J9100 Injection, cytarabine, 100 mg Valid
J9118 Injection, calaspargase pegol-mknl, 10 units Valid
J9119 Injection, cemiplimab-rwlc, 1 mg Valid
J9120 Injection, dactinomycin, 0.5 mg Valid
J9130 Dacarbazine, 100 mg Valid
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj Valid
J9145 Injection, daratumumab, 10 mg Valid
J9150 Injection, daunorubicin, 10 mg Valid
J9151 Injection, daunorubicin citrate, liposomal formulation, 10 mg through FY2026 Terminated
J9153 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine Valid
J9155 Injection, degarelix, 1 mg Valid
J9160 Injection, denileukin diftitox, 300 micrograms through FY2026 Terminated
J9161 Injection, denileukin diftitox-cxdl, 1 mcg Valid
J9165 Injection, diethylstilbestrol diphosphate, 250 mg through FY2026 Terminated
J9171 Injection, docetaxel, 1 mg Valid
J9172 Injection, docetaxel (docivyx), 1 mg Valid
J9173 Injection, durvalumab, 10 mg Valid
J9174 Injection, docetaxel (beizray), 1 mg Valid
J9175 Injection, elliotts' b solution, 1 ml Valid
J9176 Injection, elotuzumab, 1 mg Valid
Page 11 of 13